netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 31 to 60 of 62

New Newer Older Oldest

Details
UPD sitematrix Changed from 0 to
27/07/2022 14:43:49
(DavidS )
UPD FurtherInformation Changed from
27/07/2022 14:43:49
(DavidS )
UPD Atezolizumab formatting update
27/07/2022 14:43:49
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 11:12:02
(DavidS )
UPD isCyto Changed from 0 to 1
26/04/2022 11:12:02
(DavidS )
UPD Atezolizumab updated
26/04/2022 11:12:02
(DavidS )
UPD Atezolizumab Published from Draft Mode
03/02/2022 12:34:13
(DavidS )
LDL Link Added : NICE TA739: Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable : https://www.nice.org.uk/guidance/ta739
03/02/2022 11:08:55
(DavidS )
UPD sitematrix Changed from 0 to
03/02/2022 11:08:33
(DavidS )
UPD isDraft Changed from N to Y
03/02/2022 11:08:33
(DavidS )
UPD FurtherInformation Changed from
03/02/2022 11:08:33
(DavidS )
UPD Atezolizumab NICE TA739
03/02/2022 11:08:33
(DavidS )
LDL Link Added : NICE TA705: Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer : https://www.nice.org.uk/guidance/ta705
21/09/2021 10:58:58
(DavidS )
UPD sitematrix Changed from 0 to
21/09/2021 10:58:31
(DavidS )
UPD FurtherInformation Changed from
  • 1200mg/20mL concentrate for solution for infusion
21/09/2021 10:58:31
(DavidS )
UPD Atezolizumab NICE TA705
21/09/2021 10:58:31
(DavidS )
UPD Atezolizumab updated
20/05/2021 13:42:46
(LoweryM )
UPD Atezolizumab formatting updated
19/05/2021 16:43:54
(DavidS )
LDL Link Added : NICE TA666: Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma : https://www.nice.org.uk/guidance/ta666
26/02/2021 11:30:33
(DavidS )
UPD Atezolizumab updated
26/02/2021 11:30:06
(DavidS )
UPD Published from Draft Mode
14/11/2019 09:39:08
(LoweryM )
UPD Atezolizumab updated
29/10/2019 14:45:23
(DavidS )
LDL Link Added : NICE TA584: Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer : https://www.nice.org.uk/guidance/ta584
29/10/2019 14:44:13
(DavidS )
UPD Atezolizumab updated
31/07/2018 09:56:13
(LoweryM )
UPD Atezolizumab updated
30/07/2018 14:50:04
(DavidS )
UPD Atezolizumab Addition of NICE TA520 approval at APC (July 2018)
30/07/2018 14:48:38
(DavidS )
UPD Atezolizumab Published from Draft Mode
26/04/2017 10:25:58
(LoweryM )
UPD Atezolizumab updated
26/04/2017 09:01:25
(LoweryM )
LDL Link Added : Early access to medicines scheme (EAMS) scientific opinion: Atezolizumab for locally advanced or metastatic urothelial carcinoma : https://www.gov.uk/government/publications/early-access-to-medicines-scheme-eams-scientific-opinion-atezolizuma
20/04/2017 15:45:39
(DavidS )
UPD Atezolizumab a
20/04/2017 15:43:20
(DavidS )

 

 
netFormulary